Breast Cancer Diagnostics Market by Key
Segments | Forecast Years:
2022-
2027
{reportSlug=global-breast-cancer-diagnostics-market, reportId=171953, mktKeyword=Breast Cancer Diagnostics, cagr=0.00, publishDate=May 2021, priceOption2=7500, reportTitle=Breast Cancer Diagnostics Comprehensive Study by Type (Ionizing Breast Imaging Technologies (Analog Mammography, Full-Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Positron Emission Tomography/ Computed Tomography (PET/CT), Molecular Breast Imaging/ Breast Specific Gamma Imaging (MBI/BSMI), Positron Emission Mammography, and Others), Non-ionizing Imaging Technologies (Breast MRI (Magnetic Resonance Imaging), Breast Ultrasound, Optical Imaging, Automated Whole Breast Ultrasound (AWBU), and Breast Thermography)), Application (Diagnostic Clinical Laboratories, Hospitals Associated Laboratories, Ambulatory Surgical Centres, Cancer Research Centres), Test (BRCA, ER & PR, CEA, KRAS Mutation, HER 2, PSA, CA Test, EGFR Mutation Test, Immunohistochemistry, Biopsy, Blood Tests, Imaging, Genomic Tests, Others) Players and Region - Global Market Outlook to 2026, baseYr=2021, totalTableFig=217, priceOption1=3750, forecastYr=2027, noOfPages=248, reportKey=171464, breadcrum=Global Breast Cancer Diagnostics Market}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
May 2021
248 Pages
67 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries